KPMG advises JB Capital on Sesderma backed by Kartesia
KPMG has advised JB Capital on its investment in Sesderma, the dermatological laboratory founded by Dr. Gabriel Serrano, in a transaction supported by private debt investor Kartesia.
The deal marks the entry of JB Capital into the shareholding structure of one of Spain’s best-known dermatology and skincare groups. Sesderma has built a strong international presence over the years, supported by its focus on innovation, research and the development of specialised dermatological products.
The transaction comes amid continued investor interest in healthcare, wellness and consumer health businesses, sectors that have remained attractive due to their growth prospects, international expansion potential and resilient demand dynamics.
The advisers
KPMG acted as adviser to JB Capital throughout the transaction, providing multidisciplinary support across corporate finance, due diligence, legal, tax, labour, ESG and value creation matters.
The firm’s M&A team included Jose A. Zarzalejos, Javier Fernández-Miranda Allendesalazar, Alejandra Delgado Blasco, Mencía de la Lastra and Álvaro de Porras Carrique.
Financial due diligence was led by José Francisco González-Aller del Castillo and Javier Torres Montero. Legal advice was provided by Rafa Aguilar, while David Pascual advised on tax matters and Ana Gárriz García-Santamarina on labour issues.
The wider advisory team also included Ramón Pueyo Viñuales on ESG matters and Benigno Prieto from strategy & value creation.
